Enhanced immunogenicity using leukotoxin chimeras
AssigneeUniversity of Saskatchewan
InventorsAndrew A. Potter, Mark J. Redmond, Huw P. A. Hughes
Life of this patent
Estimating the term…
Abstract
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected antigen. The leukotoxin functions to increase the immunogenicity of the antigen fused thereto.
Claims19
A DNA construct encoding a chimeric protein, said DNA construct comprising a first nucleotide sequence encoding a leukotoxin polypeptide capable of activating helper T-cells directed to a selected antigen, operably linked to a second nucleotide sequence encoding said selected antigen.
Dependencies are inferred from the claim text.